(secondQuint)An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic Patients.

 This is a prospective, randomized, double-blind, placebo-controlled, ascending multiple dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics effects of VTP-43742 in healthy volunteers conducted at a single, study center and in patients with moderate to severe chronic plaque-type psoriasis at approximately 8 study centers in the United States.

 A total of 108 participants will be enrolled in the study (48 healthy subjects and 60 psoriatic patients).

.

 An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic Patients@highlight

This is a two-part, randomized, double-blind, placebo-controlled study in which VTP-43742 will be administered to normal healthy volunteers (NHV) and to moderate to severe psoriatic patients, both in sequential ascending dose panels.

